background image

Paid Clinical Trials Tacoma

Discover 1,306 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Ofatumumab

Recruiting
PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Tacoma WA, Salt Lake City UT, Los Angeles CA, Basalt COshow 20 more

Code:

NCT06869785

Conditions

Relapsing Multiple Sclerosis (RMS)

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Ofatumumab approved dose

Ofatumumab new dose

ABBV-383

Recruiting
PHASE1

Sponsor:

TeneoOne Inc.

Location:

Tacoma WA, Seattle WA, Eugene OR, Aurora COshow 19 more

Code:

NCT05650632

Conditions

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-383

MATCH

Recruiting

Sponsor:

University of Washington

Location:

Tacoma WA, Seattle WA

Code:

NCT05699252

Conditions

Chronic Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cognitive Behavioral Therapy (CBT)

Hypnotic Cognitive Therapy (HYP-CT)

Mindfulness-Based Cognitive Therapy (MBCT)

Rilvegostomig & Pembrolizumab

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Tacoma WA, Olympia WA, Salem OR, Medford ORshow 22 more

Code:

NCT06692738

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rilvegostomig

Pembrolizumab

Carboplatin

Paclitaxel

Nab-paclitaxel

NEO212

Recruiting
PHASE1
PHASE2

Sponsor:

Neonc Technologies, Inc.

Location:

Tacoma WA, Beverly Hills CA

Code:

NCT06047379

Conditions

Diffuse Astrocytoma, IDH-Mutant

Glioblastoma, IDH-wildtype

Brain Metastases, Adult

Cervical Cancer

Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NEO212 Oral Capsule

Ipilimumab

Pembrolizumab

Nivolumab

Regorafenib

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

Volrustomig

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Tacoma WA, Portland OR, Spokane WA, Santa Rosa CAshow 33 more

Code:

NCT06129864

Conditions

Locally Advanced Head and Neck Squamous Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

volrustomig

ABBV-706, Budigalimab, Cisplatin, Carboplatin

Recruiting
PHASE1

Sponsor:

AbbVie

Location:

Tacoma WA, Salt Lake City UT, Duarte CA, Irvine CAshow 17 more

Code:

NCT05599984

Conditions

Advanced Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-706

Cisplatin

Budigalimab

Carboplatin

LUT014

Recruiting
PHASE2

Sponsor:

Lutris Pharma Ltd.

Location:

Tacoma WA, Glendale CA, Santa Monica CA, Shreveport LAshow 10 more

Code:

NCT04759664

Conditions

EGFRI Induced Acneiform Lesions

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LUT014 Gel (Dose 1)

LUT014 Gel (Dose 2)

Placebo

Targeted Therapies

Recruiting
PHASE2

Sponsor:

AbbVie

Location:

Tacoma WA, Boise ID, Calgary, Edmontonshow 52 more

Code:

NCT06548542

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Risankizumab

Lutikizumab

ABBV-382

Ribociclib, Alpelisib, Everolimus

Recruiting
PHASE1

Sponsor:

Olema Pharmaceuticals, Inc.

Location:

Tacoma WA, San Francisco CA, Aurora CO, Gilbert AZshow 10 more

Code:

NCT05508906

Conditions

Metastatic Breast Cancer

Advanced Breast Cancer

ER-positive Breast Cancer

HER2-negative Breast Cancer

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OP-1250

Ribociclib

Alpelisib

Everolimus